COA ON REQUEST ≥99% PURITY SPECIFICATION FREE SHIPPING OVER $200 USA WAREHOUSE COA ON REQUEST ≥99% PURITY SPECIFICATION FREE SHIPPING OVER $200 USA WAREHOUSE
Login
← Back to Research Blog
Compounds

GHK-Cu: Why the Copper Is Not Optional

Feb 25, 2026 · 5 min read · Beginner-Friendly

GHK-Cu is glycyl-L-histidyl-L-lysine complexed with copper(II). It is a small molecule with a long research history — first isolated from human plasma in the 1970s, where its concentration was observed to decline substantially with age.

The single most common error in reading this literature is treating GHK and GHK-Cu as interchangeable. They are not, and the copper is the reason.

The copper carries the function

The tripeptide has high affinity for copper(II) and functions largely as a copper delivery vehicle. Copper is a required cofactor for a set of enzymes directly relevant to connective tissue — lysyl oxidase among them, which cross-links collagen and elastin.

This has a direct consequence for interpretation: a study using uncomplexed GHK is investigating a different entity from one using GHK-Cu, and results are not transferable between them. When reading a paper, the first thing worth checking is which form was used and whether copper was available in the medium.

What the literature reports

The best-developed areas are:

Read the concentration carefully. GHK-Cu shows biphasic behaviour in several culture systems: effects observed at low concentrations can reverse or disappear at higher ones. A negative result at a single high concentration is not evidence of no effect.

Handling

Where it came from

GHK was identified in human plasma in the early 1970s by Loren Pickart, initially through work on why young serum behaved differently from old serum in liver cell culture. The reported plasma concentration falls substantially between early adulthood and later life, and that observation has anchored the ageing framing ever since.

It is worth being precise about what a declining plasma level does and does not establish. It shows correlation with age. It does not establish that the decline causes any downstream change, nor that restoring the level reverses one. A large share of the popular claims around this molecule quietly make that leap.

Concentration is not a detail

GHK-Cu shows non-monotonic behaviour in several culture systems — effects present at nanomolar concentrations that diminish or invert at micromolar ones. Copper itself is cytotoxic above a threshold, and at higher concentrations the complex delivers enough copper to matter.

Two practical consequences follow. A single-concentration experiment is close to uninterpretable for this compound. And a negative result obtained at a high concentration may be reporting copper toxicity rather than absence of activity, which is a very different conclusion.

Distinguishing peptide from copper

Because the complex delivers copper, an obvious control is frequently missing from published work: does copper alone, at matched concentration, reproduce the effect?

A reasonably complete control set is:

Without the third arm, an effect attributed to the peptide may belong to the metal. Papers that include it are meaningfully more informative than those that do not, and it is a fast way to triage the literature.

Handling

What to be sceptical of

GHK-Cu attracts unusually broad claims, many tracing to a small number of papers by a single group. The connective-tissue and wound-healing work is reasonably solid. Claims extending well beyond that — particularly systemic ones — rest on considerably thinner evidence, and the distinction is worth maintaining.

Disclaimer

This article is for educational and informational purposes only. It is not medical advice. All products referenced are intended for research use only and are not intended for human consumption, clinical use, or the treatment of any medical condition. Always consult a licensed healthcare provider before making any health-related decisions.